Breast Cancer Clinical Trial
Intraoperative Radiation Therapy in Early Stage Breast Cancer
Summary
Single arm study to assess the effectiveness of single dose intraoperative radiation therapy in patient with in situ and early stage breast cancer.
Full Description
The purpose of this clinical study is to assess the effectiveness of IORT, using an electronic brachytherapy system, in patients with limited-volume in situ and early stage breast cancer, with endpoints of:
Local recurrence in early stage breast cancer patients treated with IORT.
Toxicity associated with IORT.
Long-term disease-specific and overall survival
Cosmetic results using the Harvard Scale at start and follow-up periods in patients treated with IORT.
Quality of life in patients treated with IORT.
Health care costs associated with IORT.
Eligibility Criteria
Inclusion Criteria:
General Inclusion Criteria
Age ≥ 45 years.
Clinical stage Tis, T1, T2 (≤ 3cm), N0, M0 (AJCC Classification).
Invasive ductal or lobular carcinoma, DCIS and/ or pleomorphic lobular carcinoma in situ.
Exclusion Criteria:
Scleroderma, systemic sclerosis and active lupus.
Participation in an investigational drug or device study.
Previous ipsilateral radiation to the thorax or breast.
Multifocal breast cancer.
Pregnant patients.
Patient not competent to provide informed consent.
Neoadjuvant systemic therapy.
Lymphovascular invasion on biopsy pathology
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Seattle Washington, 98101, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.